1TA6 | Hydrolase Hydrolase Inhibitor | date | May 19, 2004 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Thrombin In Complex With Compound 14b | ||||||||||||||
authors | T.J.Tucker, S.F.Brady, W.C.Lumma, S.D.Lewis, S.J.Gardel, A.M.Nayl Y.Yan, J.T.Sisko, K.J.Stauffer, B.Y.Lucas, J.J.Lynch, J.J.Cook, M.T.Stranieri, M.A.Holahan, E.A.Lyle, E.P.Baskin, I.W.Chen, K.B.Dancheck, J.A.Krueger, C.M.Cooper, J.P.Vacca | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Thrombin Chain: A Fragment: Alpha-Thrombin Synonym: Coagulation Factor II Ec: 3.4.21.5 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Organ: Pancreas | ||||||||||||||
Molecule: Hirudin Chain: B Engineered: Yes |
Synthetic: Yes | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | 177, TYS BindingDB | enzyme | Hydrolase E.C.3.4.21.5 BRENDA | ||||||||||||
related structures | by homologous chain: 1C5O, 1NO9, 1SB1 | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position., Tucker TJ, Brady SF, Lumma WC, Lewis SD, Gardell SJ, Naylor-Olsen AM, Yan Y, Sisko JT, Stauffer KJ, Lucas BJ, Lynch JJ, Cook JJ, Stranieri MT, Holahan MA, Lyle EA, Baskin EP, Chen IW, Dancheck KB, Krueger JA, Cooper CM, Vacca JP, J Med Chem 1998 Aug 13;41(17):3210-9. PMID:9703466 |
Data retrieval |
View 1TA6 in 3D |
Visual 3D analysis of 1TA6 |
Structure-derived information |
- Domain d1ta6a_, region A [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1TA6 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |